Patent: 10,071,139
✉ Email this page to a colleague
Summary for Patent: 10,071,139
| Title: | Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragment |
| Abstract: | Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The methods include administering a fragment of ANGPTL8 to a subject having or at risk of developing elevated triglyceride levels, elevated total cholesterol levels and/or elevated LDL cholesterol levels. |
| Inventor(s): | Liu; Zhonghao (San Bruno, CA), Ding; Xunshan (San Bruno, CA) |
| Assignee: | NGM Biopharmaceuticals, Inc. (South San Francisco, CA) |
| Application Number: | 15/318,937 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,071,139
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2034-10-03 |
| Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2034-10-03 |
| Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2034-10-03 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
